Live na paghahanap
Hinahanap ng TopFind ang pinakabagong resulta para sa iyong paghahanap.
Sinuri namin ang 195 live na resulta para sa semi daonil at pinaliit ito sa 3 opsyon na pinakakarapat-dapat ihambing muna.
Ang pinakamalakas na tema sa maikling listahang ito ay Antidiabetic at Prescription Medicine.
Pinagmulan: Sanofi-Aventis Singapore Pte Ltd
Paglalarawan
Semi-Daonil is a lower-dose formulation of the antidiabetic drug Glibenclamide, containing 2.5 mg per tablet. This version is specifically designed for patients who require precise dose titration or a smaller maintenance dose to manage their Type 2 diabetes effectively without excessive risk of hypoglycemia.
Pinakamainam para sa
Dosage titration, Maintenance therapy at Type 2 diabetes control
Rating
Pinagmulan: Sanofi-Aventis Singapore Pte Ltd
Paglalarawan
Daonil is a prescription-only oral antidiabetic medication containing 5 mg of Glibenclamide (a sulfonylurea). It is used for the management of Type 2 diabetes mellitus to help lower blood glucose levels by stimulating the pancreas to release more insulin. It is a long-standing treatment option registered with the Health Sciences Authority (HSA) and listed on the National Drug Formulary.
Pinakamainam para sa
Type 2 diabetes patients, Blood sugar management, Sulfonylurea therapy at Prescription medication
Rating
Pinagmulan: Sanofi-Aventis Singapore Pte Ltd
Paglalarawan
Daonil M is a combination medication that integrates Glibenclamide with Metformin. This dual-action antidiabetic treatment targets Type 2 diabetes mellitus through two different mechanisms: increasing insulin production and improving the body's response to insulin, providing comprehensive glucose control in a single tablet.
Pinakamainam para sa
Dual Action glucose control, Combination therapy at Type 2 diabetes management
Rating
| Ihambing | Semi-Daonil | Daonil | Daonil M |
|---|---|---|---|
| Pinagmulan | Sanofi-Aventis Singapore Pte Ltd | Sanofi-Aventis Singapore Pte Ltd | Sanofi-Aventis Singapore Pte Ltd |
| Paglalarawan | Semi-Daonil is a lower-dose formulation of the antidiabetic drug Glibenclamide, containing 2.5 mg per tablet. This version is specifically designed for patients who require precise dose titration or a smaller maintenance dose to manage their Type 2 diabetes effectively without excessive risk of hypoglycemia. | Daonil is a prescription-only oral antidiabetic medication containing 5 mg of Glibenclamide (a sulfonylurea). It is used for the management of Type 2 diabetes mellitus to help lower blood glucose levels by stimulating the pancreas to release more insulin. It is a long-standing treatment option registered with the Health Sciences Authority (HSA) and listed on the National Drug Formulary. | Daonil M is a combination medication that integrates Glibenclamide with Metformin. This dual-action antidiabetic treatment targets Type 2 diabetes mellitus through two different mechanisms: increasing insulin production and improving the body's response to insulin, providing comprehensive glucose control in a single tablet. |
| Pinakamainam para sa | Dosage titration, Maintenance therapy at Type 2 diabetes control | Type 2 diabetes patients, Blood sugar management, Sulfonylurea therapy at Prescription medication | Dual Action glucose control, Combination therapy at Type 2 diabetes management |
| Aksyon | |||
| Rating |
Kung gusto mong magsimula sa pinakabalanse na opsyon, inirerekomenda ko ang:
"Semi-Daonil mula sa Sanofi-Aventis Singapore Pte Ltd."
Pinili ko ito dahil Offers flexibility for healthcare providers to tailor dosage according to specific patient needs, especially during the early stages of treatment.